It said the violations breach the Pharmaceutical Affairs Act and will carry fines ranging from NT$30,000 to NT$5 million
When you embark on a medical weight loss program at Aspire MedSpa, you arent just receiving a prescription
Conversely, low-dose GLP-1 therapy is not appropriate for patients without established indications, particularly those seeking anti-inflammatory effects alone without diabetes or obesity
Preclinical Data Point to a Meaningful Competitive Edge Preclinical data from SureNano Science suggest that GEP-44 may offer substantive differentiation relative to earlier-generation GLP therapies
This study was intended to provide descriptive insights into the real-world use, weight outcomes, and dosing among patients treated with semaglutide 2.4 mg and tirzepatide
We are now seeing many more research studies for other indications and treatment with these drugs